- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04013152
Clinical Database of Colorectal Robotic Surgery (ROBOT CR)
French Prospective Clinical Database of Colorectal Robotic Surgery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Since the emergence of minimally invasive technology twenty years ago, as a surgical concept and surgical technique for colorectal cancer surgery, its obvious advantages have been recognized.
Laparoscopic technology, as one of the most important technology platform, has got a lot of evidence-based support for the oncological safety and effectiveness in colorectal cancer surgery Laparoscopic technique has advantages in terms of identification of anatomic plane and autonomic nerve, protection of pelvic structure, and fine dissection of vessels.
But because of the limitation of laparoscopic technology there are still some deficiencies and shortcomings, including lack of touch and lack of stereo vision problems, in addition to the low rectal cancer, especially male, obese, narrow pelvis, larger tumors, it is difficult to get better view and manipulating triangle in laparoscopy. However, the emergence of a series of new minimally invasive technology platform is to make up for the defects and deficiencies. The robotic surgical system possesses advantages, such as stereo vision, higher magnification, manipulator wrist with high freedom degree, filtering of tremor and higher stability, but still has disadvantages, such as lack of haptic feedback, longer operation time, high operation cost and expensive price.
3D system of laparoscopic surgery has similar visual experience and feelings as robotic surgery in the 3D view, the same operating skills as 2D laparoscopy and a short learning curve. Transanal total mesorectal excision (taTME) by changing the traditional laparoscopic pelvic surgery approach, may have certain advantages for male cases with narrow pelvic and patients with large tumor.
No prospective study has compared these four surgical techniques. Furthermore, the learning curve still remains a crucial problem in term of data interpretation.
We will collect synchronized videos and data on surgeon performance during colorectal surgeries using the Vinci Logger (dVLogger, Intuitive Surgical, Inc.), it is a personalized recording tool that captures synchronized video in the form of endoscope view at 30 frames per second. Kinematic data included characteristics of movement such as instrument travel time, path length and velocity. Events included frequency of master controller clutch use, camera movements, third arm swap and energy use.
We will explore and validate objective surgeon performance metrics using novel recorder ("dVLogger") to directly capture surgeon manipulations on the daVinci Surgical System.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Gironde
-
Bordeaux, Gironde, France, 33600
- CHU de Bordeaux
-
-
Hérault
-
Montpellier, Hérault, France, 34298
- Institut Régional du Cancer de Montpellier
-
-
Puy De Dôme
-
Clermont-Ferrand, Puy De Dôme, France, 63103
- CHU de Clermont-Ferrand
-
-
Rhône
-
Lyon, Rhône, France, 69310
- CHU de Lyon
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Male or female ≥ 18 years
- Colorectal pathologies (Crohn's disease, Polyposis, Ulcerative colitis, Diverticulitis, Colorectal tumor, Rectal prolapse, Benign and colorectal tumor) eligible for robotic surgery.
- Major techniques: right and left colectomy, rectal excision (low anterior resection, intersphincteric resection, abdominoperineal resection), Hartman reversal
- Or, Minor techniques: rectopexy, shaving for rectal endometriosis,
- Or, Complex techniques: extended rectal excision for T4 cancer, pelvectomy, redo surgery.
- Patient affiliated to a social security regimen
- Patient information for study
Exclusion Criteria:
- Legal incapacity or physical, psychological social or geographical status interfering with the patient's ability to agree to participate in the study
- Patient under tutelage, curatorship or safeguard of justice
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
clinical database
|
Constitution of a prospective, multicenter clinical database of surgery with robotic assistance in colorectal pathologies
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Collection of clinical data following surgery with robotic assistance in colorectal pathologies
Time Frame: 3 years
|
3 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
overall survival
Time Frame: 8 years
|
8 years
|
|
Time of learning for each surgical technique by determining a learning curve for each of them
Time Frame: 3 years
|
3 years
|
|
The conversion rate of surgical technique
Time Frame: 3 years
|
3 years
|
|
Operating time
Time Frame: 3 years
|
3 years
|
|
Intraoperative complications rate
Time Frame: 3 years
|
3 years
|
|
Duration of hospital stay
Time Frame: 1 month
|
1 month
|
|
local relapse-free survival
Time Frame: 8 years
|
8 years
|
|
Digestive functionality assessment by using the Low Anterior Resection Syndrome score (LARS)
Time Frame: 3 years
|
This questionnaire assessed the bowel function of patient.
The range is from 8 (low function) to 35 (high function)
|
3 years
|
The Erectile Function of patient by using the II-EF-5 score (The International Index of Erectile Function)
Time Frame: 3 years
|
The range is from 1 (low erectile function) to 27 (high erectile function)
|
3 years
|
The dysfunction of female Sexual Function by using the Index FSFI (The Female Sexual Function Index) score
Time Frame: 3 years
|
The range is from 3 (low sexual function) to 55 (high sexual function).
|
3 years
|
Urinary functionality by using the questionnaire of urinary function
Time Frame: 3 years
|
The range is from 0 (low urinary function) to 40 (high urinary function).
|
3 years
|
Objective surgeon performance metrics using a novel recorder (dVLogger) to directly capture surgeon manipulations on the da Vinci Surgical System
Time Frame: 3 years
|
3 years
|
|
Number of lymph node resected
Time Frame: 3 years
|
3 years
|
|
Quality of the mesorectum by using Quirke classification
Time Frame: 3 years
|
The quality of the mesorectum resection is determined by the pathologist according to the aspect of mesorectum, the circumferential resection margin, cone effect .
|
3 years
|
Collaborators and Investigators
Investigators
- Study Chair: Philippe Rouanet, MD, Institut Régional du Cancer de Montpellier
Publications and helpful links
General Publications
- Colombo PE, Bertrand MM, Alline M, Boulay E, Mourregot A, Carrere S, Quenet F, Jarlier M, Rouanet P. Robotic Versus Laparoscopic Total Mesorectal Excision (TME) for Sphincter-Saving Surgery: Is There Any Difference in the Transanal TME Rectal Approach? : A Single-Center Series of 120 Consecutive Patients. Ann Surg Oncol. 2016 May;23(5):1594-600. doi: 10.1245/s10434-015-5048-4. Epub 2015 Dec 29.
- Bertrand MM, Colombo PE, Mourregot A, Traore D, Carrere S, Quenet F, Rouanet P. Standardized single docking, four arms and fully robotic proctectomy for rectal cancer: the key points are the ports and arms placement. J Robot Surg. 2016 Jun;10(2):171-4. doi: 10.1007/s11701-015-0551-y. Epub 2015 Dec 8.
- Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH; Cooperative Clinical Investigators of the Dutch Colorectal Cancer Group. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol. 2002 Apr 1;20(7):1729-34. doi: 10.1200/JCO.2002.07.010.
- Chen SL, Steele SR, Eberhardt J, Zhu K, Bilchik A, Stojadinovic A. Lymph node ratio as a quality and prognostic indicator in stage III colon cancer. Ann Surg. 2011 Jan;253(1):82-7. doi: 10.1097/SLA.0b013e3181ffa780.
- Zhang X, Wei Z, Bie M, Peng X, Chen C. Robot-assisted versus laparoscopic-assisted surgery for colorectal cancer: a meta-analysis. Surg Endosc. 2016 Dec;30(12):5601-5614. doi: 10.1007/s00464-016-4892-z. Epub 2016 Jul 11.
- Parc Y, Reboul-Marty J, Lefevre JH, Shields C, Chafai N, Tiret E. Factors influencing mortality and morbidity following colorectal resection in France. Analysis of a national database (2009-2011). Colorectal Dis. 2016 Feb;18(2):205-13. doi: 10.1111/codi.13099.
- Bege T, Lelong B, Esterni B, Turrini O, Guiramand J, Francon D, Mokart D, Houvenaeghel G, Giovannini M, Delpero JR. The learning curve for the laparoscopic approach to conservative mesorectal excision for rectal cancer: lessons drawn from a single institution's experience. Ann Surg. 2010 Feb;251(2):249-53. doi: 10.1097/SLA.0b013e3181b7fdb0.
- Poloniecki J, Valencia O, Littlejohns P. Cumulative risk adjusted mortality chart for detecting changes in death rate: observational study of heart surgery. BMJ. 1998 Jun 6;316(7146):1697-700. doi: 10.1136/bmj.316.7146.1697. Erratum In: BMJ 1998 Jun 27;316(7149):1947.
- Guend H, Widmar M, Patel S, Nash GM, Paty PB, Guillem JG, Temple LK, Garcia-Aguilar J, Weiser MR. Developing a robotic colorectal cancer surgery program: understanding institutional and individual learning curves. Surg Endosc. 2017 Jul;31(7):2820-2828. doi: 10.1007/s00464-016-5292-0. Epub 2016 Nov 4.
- Bokhari MB, Patel CB, Ramos-Valadez DI, Ragupathi M, Haas EM. Learning curve for robotic-assisted laparoscopic colorectal surgery. Surg Endosc. 2011 Mar;25(3):855-60. doi: 10.1007/s00464-010-1281-x. Epub 2010 Aug 24.
- Bolsin S, Colson M. The use of the Cusum technique in the assessment of trainee competence in new procedures. Int J Qual Health Care. 2000 Oct;12(5):433-8. doi: 10.1093/intqhc/12.5.433.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Neoplasms
- Neoplasms by Site
- Gastrointestinal Neoplasms
- Digestive System Neoplasms
- Gastrointestinal Diseases
- Gastroenteritis
- Colonic Diseases
- Intestinal Diseases
- Pathological Conditions, Anatomical
- Intestinal Neoplasms
- Rectal Diseases
- Inflammatory Bowel Diseases
- Diverticular Diseases
- Pelvic Organ Prolapse
- Colorectal Neoplasms
- Prolapse
- Crohn Disease
- Colitis
- Diverticulitis
- Rectal Prolapse
Other Study ID Numbers
- PROICM 2017-05 ROB
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Crohn Disease
-
ProgenaBiomeRecruitingCrohn Disease | Crohn Colitis | Crohn's Ileocolitis | Crohn's Gastritis | Crohn's Jejunitis | Crohn's Duodenitis | Crohn's Esophagitis | Crohn's | Crohn Disease of Ileum | Crohn Ileitis | Crohn's Disease Relapse | Crohns Disease Aggravated | Crohn Disease in Remission | Crohn's Disease of PylorusUnited States
-
Chinese University of Hong KongTerminatedCrohn Disease | Perianal Crohn DiseaseHong Kong
-
SandozCompletedCrohn´s DiseaseAustria, Germany, Poland, Spain, Sweden
-
Dr. Falk Pharma GmbHCompleted
-
University of Erlangen-Nürnberg Medical SchoolCompleted
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CelltrionRecruitingBowel Disease | Inflammatory Disease | Disease CrohnNetherlands
-
Ferring PharmaceuticalsTerminatedCrohn´s DiseaseUnited Kingdom, United States, Germany, Belgium, Denmark, France, Sweden
-
Groupe Hospitalier Paris Saint JosephCompleted
-
Jinling Hospital, ChinaCompletedCrohn Disease in RemissionChina
-
Boehringer IngelheimTerminatedFibrostenotic Crohn´s DiseaseUnited States, Canada, Japan, Sweden
Clinical Trials on Clinical database
-
Institut du Cancer de Montpellier - Val d'AurelleActive, not recruiting
-
Institut du Cancer de Montpellier - Val d'AurelleCompletedProstate Cancer | Bone Metastases | Hormone-resistant Prostate CancerFrance
-
Institut Claudius RegaudRecruiting
-
King Faisal Specialist Hospital & Research CenterUnknownLymphoma, Non-Hodgkin | Hodgkin DiseaseSaudi Arabia
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingAcute Coronary Syndrome | Myocardium; InjuryItaly
-
King Faisal Specialist Hospital & Research CenterUnknown
-
King Faisal Specialist Hospital & Research CenterUnknownLymphoma, Non-Hodgkin | Hodgkin DiseaseSaudi Arabia
-
RWTH Aachen UniversityRecruitingIntensive Care in GeneralGermany
-
King Faisal Specialist Hospital & Research CenterUnknownLeukemia, Myeloblastic, Acute
-
Centre Hospitalier Universitaire, AmiensWithdrawn